Risk stratification of sudden cardiac death: a review

J Tfelt-Hansen, R Garcia, C Albert, J Merino, A Krahn… - Europace, 2023‏ - academic.oup.com
Sudden cardiac death (SCD) is responsible for several millions of deaths every year and
remains a major health problem. To reduce this burden, diagnosing and identification of …

2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their …

MK Stiles, AAM Wilde, DJ Abrams… - Journal of …, 2021‏ - Wiley Online Library
This international multidisciplinary document intends to provide clinicians with evidence‐
based practical patient‐centered recommendations for evaluating patients and decedents …

Adverse reactions induced by MDT/WHO (Rifampicin+ Clofazimine+ Dapsone) and ROM (Rifampicin+ Ofloxacin+ Minocycline) regimens used in the treatment of …

IC Celestino, DE Antunes, DF Santos… - Frontiers in …, 2024‏ - frontiersin.org
Background: Recommended standard treatment for leprosy is multidrugtherapy (MDT/WHO),
consisting Rifampicin+ Dapsone+ Clofazimine. Other medications are recommended in …

Association of QT-prolonging medications with risk of autopsy-defined causes of sudden death

TF Simpson, JW Salazar, E Vittinghoff… - JAMA Internal …, 2020‏ - jamanetwork.com
Importance QT-prolonging medications (QTPMs) are a reported risk factor for sudden
cardiac death (SCD) when defined by consensus criteria that presume an arrhythmic cause …

[HTML][HTML] Current behavior of sudden cardiac arrest and sudden death

H Rodríguez-Reyes, M Muñoz-Gutiérrez… - … de cardiología de …, 2020‏ - scielo.org.mx
Sudden cardiac arrest (SCA) and sudden death (SD) continue to be a global public health
problem, although the true incidence is unknown, it is estimated that they are responsible for …

[HTML][HTML] Multilead QT screening is necessary for QT measurement: implications for management of patients in the COVID-19 era

CC Cheung, B Davies, K Gibbs, ZW Laksman… - Clinical …, 2020‏ - jacc.org
This study received ethical approval from the University of British Columbia clinical research
ethics board. We performed a prospective evaluation of the handheld electrocardiographic …

Toxicological profile using mass spectrometry in sudden cardiac arrest survivors admitted to a tertiary centre

NK Stampe, C Glinge, BS Rasmussen, P Bhardwaj… - Resuscitation, 2024‏ - Elsevier
Background There has been no previous thorough toxicological examination of a cohort of
patients with resuscitated sudden cardiac arrest. We aimed to determine the qualitative and …

Nationwide burden of sudden cardiac death among patients with a psychiatric disorder

J Mujkanovic, PE Warming, LV Kessing, LV Køber… - Heart, 2024‏ - heart.bmj.com
Background Patients with psychiatric disorders have increased all-cause mortality compared
with the general population. Previous research has shown that there is a fourfold increased …

Proarrhythmic drugs, drug levels, and polypharmacy in victims of sudden arrhythmic death syndrome: An autopsy-based study from Denmark

MK Palsøe, CJ Hansen, C Torp-Pedersen, BG Winkel… - Heart Rhythm, 2024‏ - Elsevier
Background Sudden arrhythmic death syndrome (SADS), characterized by an unknown or
inconclusive cause of death at autopsy together with a negative or nonlethal toxicology …

Differential effects on out-of-hospital cardiac arrest of dihydropyridines: real-world data from population-based cohorts across two European countries

TE Eroglu, GH Mohr, MT Blom… - European Heart …, 2020‏ - academic.oup.com
Aims Various drugs increase the risk of out-of-hospital cardiac arrest (OHCA) in the general
population by impacting cardiac ion channels, thereby causing ventricular …